Israeli scientists redesign T cells, shrinking tumors in promising cancer study

Ynetnews Культура

T cells can precisely target cancer, but engineered receptors may interfere with natural ones and lose effectiveness; Bar-Ilan and Weizmann researchers designed a more stable version, with promising results in mice